Chlorpromazine: from antihistamine to antipsychotic
While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.
New recommendations for patients with mild asthma
The latest version of the Australian Asthma Handbook includes a new treatment option for adults and adolescents with mild asthma.
Eye protection important for regular mask users
A new Pharmaceutical Benefits Scheme listing last week for dry eye product Cationorm ties into a quirky review of a new area of literature from United States researchers.
The prescribing pharmacist
James Buckley, fitness fanatic and partner at LiveLife Pharmacy Port Douglas, is full speed into the expanded Queensland prescribing pilot.
Telehealth medication reviews introduced
Pharmacists can now conduct funded medication reviews via video or teleconference, in a move that will bolster medicine safety as the COVID-19 pandemic continues.
Limited evidence for medicinal cannabis in most mental health conditions
A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.
